Design Therapeutics Inc. logo

Design Therapeutics Inc.

DSGN | NASDAQ
Chart Builder DCF Calculator
$12.87
+$0.32 (+2.55%)
Sep 22, 2026, 10:50 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-69.79M -49.59M -66.86M -63.31M -35.53M -8.28M
Depreciation & Amortization
622K 596K 537K 406K 129K 5K
Stock-Based Compensation
14.55M 13.07M 13.09M 10.93M 4.69M 450K
Other Working Capital
-1.38M 226K 1.97M -3.39M -1.02M -398K
Other Non-Cash Items
-2.85M -6.19M -6.05M -1.33M -58K -33K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
3.11M -993K 728K 1.99M 1.4M -811K
Operating Cash Flow
-54.36M -43.11M -58.56M -51.32M -29.38M -8.67M
Capital Expenditures
-193K -340K -256K -918K -1.54M -76K
Cash Acquisitions
n/a n/a n/a 39K 52.11K n/a
Purchase of Investments
-291.78M -230.18M -224.7M -313M -86.26M -55.59M
Sales Maturities Of Investments
314.89M 274.47M 277.5M 92.89M 34.16M 22.1M
Other Investing Acitivies
n/a n/a n/a n/a -52.11K n/a
Investing Cash Flow
22.91M 43.96M 52.54M -220.99M -53.64M -33.56M
Debt Repayment
n/a n/a n/a n/a n/a -200K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a -427K 228K 1K
Financial Cash Flow
25.74M 513K 724K 235K 379.21M 44.53M
Net Cash Flow
-5.71M 1.36M -5.3M -272.07M 296.19M 2.3M
Free Cash Flow
-54.55M -43.45M -58.82M -52.24M -30.92M -8.75M
Adj. Free Cash Flow
-69.1M -56.52M -71.9M -63.16M -35.6M -9.2M
Maintenance CapEx
-193K -340K -256K -918K -1.54M -76K
Growth CapEx
n/a n/a n/a n/a n/a n/a
Owner Earnings
-54.55M -43.45M -58.82M -52.24M -30.92M -8.75M

© 2026 bestshares.com. All rights reserved.